Life Sciences Attorneys Present at Food and Drug Law Institute Biologicals Law Course

October 2, 2019
Capital Insights.

Life sciences regulatory & compliance counsel Beth Weinman and associate Joshua Oyster (both of Washington, D.C.) will speak at the Food and Drug Law Institute’s Introduction to Biologics and Biosimilars Law and Regulation on a panel titled “Violations, Enforcement and International Issues” on October 2 in

The panel will address topics including FDA criminal, civil, and regulatory enforcement authorities and tools, inspection procedures, international harmonization and import and export issues related to biologics and biosimiliars.

The FDLI program will explore biological product regulation including biotechnology-derived therapeutic proteins, human tissue, gene and cell products.